Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc.

Immunomic Therapeutics, Inc.

Overview
Date Founded

2011

Headquarters

15010 Broschart Road,Suite 250,Rockville, MD 20850

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Biotechnology
Holding Companies
Pharmaceuticals

Company Description

Immunomic Therapeutics, Inc. engages in the discovery and development of drugs. The firm specializes in DNA vaccines, lamp technology, allergy, oncology, animal health and infectious diseases. The company was founded by William G. Hearl and Thomas J. August in 2005 and is headquartered in Hershey, PA.

Website

http://www.immunomix.com

Contact Data
Trying to get in touch with decision makers at Immunomic Therapeutics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
November 27, 2019
Cancer Therapeutics Market Size to Reach US$ 176 Bn by 2026; Acumen Research and Consulting, Recently Published Report on "Cancer Therapeutics Market Size, Share, Sales, Growth Opportunities and Forecast, 2019 - 2026"
Business Wire
November 21, 2019
Immunomic Therapeutics' Collaborator, University of Florida Presents New Clinical Data from ATTAC-II Study in GBM at the 2019 Society for Neurology (SNO) Annual Meeting
Business Wire
November 4, 2019
Immunomic Therapeutics Announces Presentations at Upcoming Scientific and Medical Conferences
ENP Newswire
October 21, 2019
-Immunomic Therapeutics to Present at Precision Lung Cancer World RD Summit
Business Wire
October 18, 2019
Immunomic Therapeutics to Present at the First International Symposium on Merkel Cell Carcinoma 2019; -Data demonstrates that UNITE, as a nucleic acid platform, elicits potent immune responses

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Executives & Employees
See More
William G. Hearl

Founder

C Eric Winzer

Chief Financial Officer

Teri Jones Heiland

Chief Scientific Officer

W. Barry McDonald

Head-Business Development

Athanasia Anagnostou

Senior Director

Gabriela Lavezzari

Lab Director

Colin Magowan

Director-Business Development

Eliezer Romeu

Marketing Manager

Ido Weiss

Scientist

Louise Peltier

Board of Directors
Ronald P. Thiboutot

Executive Vice President at Life Sciences Greenhouse of Central Pennsylvania

C Eric Winzer

Chief Financial Officer at Immunomic Therapeutics, Inc.

Michael D. Lack

Former Chief Executive Officer at Lpath Inc.

W. Barry McDonald

Chief Executive Officer at McDonald & Associates, Inc.

Trending People
British Labour Party
Uncertainty the Only Certainty in 2020 - AI-CIO
US House of Representatives
U.S. House to proceed with articles of impeachmentPelosi says body has 'no choic... - The San Diego Union-Tribune
U.S. Department of Defense
Amazon Is Blaming Trump For Losing The Pentagon Contract, Judge Says - Fortune
Uber Technologies, Inc.
The World’s Most Valuable Company - Fortune
The Walt Disney Company
In the wake of Avengers: Endgame, 2020 is the year of female superhero movies... - CNET
Trending Organizations
British Labour Party
Uncertainty the Only Certainty in 2020 - AI-CIO
US House of Representatives
U.S. House to proceed with articles of impeachmentPelosi says body has 'no choic... - The San Diego Union-Tribune
U.S. Department of Defense
Amazon Is Blaming Trump For Losing The Pentagon Contract, Judge Says - Fortune
Uber Technologies, Inc.
The World’s Most Valuable Company - Fortune
The Walt Disney Company
In the wake of Avengers: Endgame, 2020 is the year of female superhero movies... - CNET
Paths to Immunomic Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Immunomic Therapeutics, Inc.
Recent Transactions
Details Hidden

Immunomic Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Immunomic Therapeutics, Inc. raised money in a private placement transaction

Details Hidden

Immunomic Therapeutics, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor
Newport Coast Securities, Inc.

Advised onImmunomic Therapeutics, Inc. raised money in a private placement transaction
Clients
Astellas Pharma, Inc.

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases. The firm's global brands include Prograf, Vesicare, Protopic, Harnal, and Funguard. The company is headquartered in Tokyo, Japan.
Investors
Details Hidden
Brainchild Holdings LLC

Brainchild Holdings invests in companies located in the US. They focus on business to business, consumer, e-commerce & health sector. The firm provides financing for seed, early & growth stage transactions.

Details Hidden
Life Sciences Greenhouse of Central Pennsylvania

The Life Sciences Greenhouse of Central Pennsylvania makes pre-seed and seed stage investments in life sciences companies. Areas of particular interest to include mid- to-late stage drug design, drug delivery systems, biomedical devices, biopharmaceutical manufacturing innovation, drug assay/detection/screening systems and bionanotechnology. Investments range up to $750,000 in milestone-driven convertible debt or equity financing. They focus on investments in Central Pennsylvania.

Details Hidden
Bespoke Capital LLC

Bespoke Capital makes both equity and debt investments in innovative companies with high large growth potential.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 11 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Immunomic Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Immunomic Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Immunomic Therapeutics, Inc..